Xin, Z., Peiying, Y., & Guangxian, M. (2025). High expression of folate metabolic pathway gene MTHFD2 is related to the poor prognosis of patients and may apply as a potential new target for therapy of NSCLC. De Gruyter.
Chicago Style (17th ed.) CitationXin, Zhang, Yang Peiying, and Meng Guangxian. High Expression of Folate Metabolic Pathway Gene MTHFD2 Is Related to the Poor Prognosis of Patients and May Apply as a Potential New Target for Therapy of NSCLC. De Gruyter, 2025.
MLA (9th ed.) CitationXin, Zhang, et al. High Expression of Folate Metabolic Pathway Gene MTHFD2 Is Related to the Poor Prognosis of Patients and May Apply as a Potential New Target for Therapy of NSCLC. De Gruyter, 2025.
Warning: These citations may not always be 100% accurate.